Table 3 Efficacy of PTNS in chronic pelvic pain/painful bladder syndrome
Authors | Years | Control group | PNT | Other | RCT | Methods | Level | Results | Female (%) | Mean age (range) | Multicenter | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Positive | % | n | Positive | % | PNT group | Control group | PNT group | Control group | ||||||||
van Balken MR | 2003 [27] | N/A | 33 | 14 | 42 | N | Clinical | 3 | Mean VAS for pain | 33 | 51.6 (25–79) | N | |||||
Kim SW | 2007 [28] | N/A | 15 | 9 | 60 | N | Clinical | 3 | VAS score for pain reduction >50% | 60 (41–78) | N | ||||||
Kabay S | 2009 [29] | Sham | 45 | 18 | 40 | 44 | 0 | 0 | Y | Clinical | 1 | VAS score for pain reduction >50% | 0 | 0 | 37.9 (range 24–51) | 38.5 (range 25) | N |
Zhao J | 2004 [31] | N/A | 14 | 0 | 0 | N | Clinical | 3 | VAS Scale reduction | 93 | N | ||||||
Zhao J | 2008 [31] | N/A | 18 | 8 | 44 | N | Clinical | 3 | Bladder capacity increases | 100 | 60 | N | |||||
Baykal K | 2005 [32] | N/A | 10 | 10 | 100 | N | Clinical | 3 | Wiscosin pain score | 80 | 49 (40–62) | N | |||||
Congregado Ruiz B | 2004 [33] | N/A | 51 | 51 | 100 | N | Clinical | Improvement QoL | 100 | 55 (18–74) | N | ||||||
Gokyildiz S | 2012 [34] | No treatment | 12 | 12 | 100 | 12 | 0 | 0 | Y | Clinical | Improvement QoL | 100 | 100 | / | / | N | |